1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Research Methodology
   1. Qualitative Research
   2. Methodology
   3. Regional Split of Primary & Secondary Research
   4. Secondary Research
   5. Primary Research
      1. Breakdown of Primary Research Respondents, By Region
         1. Breakdown of Primary Research Respondents, By Industry Participants
   6. Market Size Estimation
   7. Assumptions for the Study
   8. Market Breakdown & Data Triangulation
3. Executive Summary
4. Industry Insight and Growth Strategy
   1. Value Chain Analysis
   2. DROC Analysis
      1. Market Drivers
         1. Increasing Prevalence of Various Types Of Cancer
         2. Expanding R&D Activities In The Development Of Anticancer Drugs
      2. Market Restraints
         1. Adverse Side Effects of Anticancer Drugs
      3. Market Challenges
         1. High Price of Anticancer Drugs
      4. Market Opportunity
         1. Increasing Adoption of Target Therapies for Cancer Treatment
         2. Growing Demand for Injectables
   3. Recent Developments
   4. Porter’s Five Forces Analysis
      1. Bargaining Power of Buyers
      2. Bargaining Power of Suppliers
      3. Intensity of Rivalry
      4. Threat of New Entrants
      5. Threat of Substitutes
5. Global Anticancer Drugs Market Overview
   1. Market Estimates & Forecast by Value, 2017-2027
   2. Market Share & Forecast
      1. By Drug Class
         1. Cytotoxic Drugs
            1. Alkylating Agents
            2. Antimetabolites
            3. Others
         2. Targeted Drugs
            1. Monoclonal Antibodies
            2. Others
         3. Hormonal Drugs
      2. By Therapy
         1. Chemotherapy
         2. Targeted Therapy
         3. Immunotherapy
      3. By Indication
         1. Lung Cancer
         2. Breast Cancer
         3. Stomach Cancer
         4. Colorectal Cancer
         5. Prostate Cancer
         6. Others
      4. By Dosage Form
         1. Solid
            1. Tablets
            2. Capsules
         2. Liquid
         3. Injectable
            1. Prefilled Syringes
            2. others
      5. By Distribution Channel
         1. Hospital Pharmacies
         2. Retail Pharmacies
         3. Online
         4. Others
      6. By Region
         1. North America
         2. Europe
         3. Asia-Pacific (APAC)
         4. Latin America (LATAM)
         5. Middle-East & Africa (MEA)
6. North America Anticancer Drugs Market Overview
   1. Market Size and Forecast
      1. By Value (USD Million), 2017-2027
   2. Market Share and Forecast
      1. By Drug Class
      2. By Therapy
      3. By Indication
      4. By Dosage Form
      5. By Distribution Channel
      6. By Country
         1. U.S.
         2. Canada
7. Europe Anticancer Drugs Market Overview
   1. Market Size and Forecast
      1. By Value (USD Million), 2017-2027
   2. Market Share and Forecast
      1. By Drug Class
      2. By Therapy
      3. By Indication
      4. By Dosage Form
      5. By Distribution Channel
      6. By Country
         1. Germany
         2. U.K.
         3. France
         4. Italy
         5. Spain
         6. Netherlands
         7. Rest of Europe
8. APAC Anticancer Drugs Market Overview
   1. Market Size and Forecast
      1. By Value (USD Million), 2017-2027
   2. Market Share and Forecast
      1. By Drug Class
      2. By Therapy
      3. By Indication
      4. By Dosage Form
      5. By Distribution Channel
      6. By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Rest of APAC
9. LATAM Anticancer Drugs Market Overview
   1. Market Size and Forecast
      1. By Value (USD Million), 2017-2027
   2. Market Share and Forecast
      1. By Drug Class
      2. By Therapy
      3. By Indication
      4. By Dosage Form
      5. By Distribution Channel
      6. By Country
         1. Mexico
         2. Brazil
         3. Rest of LATAM
10. MEA Anticancer Drugs Market Overview
    1. Market Size and Forecast
       1. By Value (USD Million), 2017-2027
    2. Market Share and Forecast
       1. By Drug Class
       2. By Therapy
       3. By Indication
       4. By Dosage Form
       5. By Distribution Channel
       6. By Country
          1. Saudi Arabia
          2. UAE
          3. South Africa
          4. Rest of Europe
11. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Market Share / Ranking Analysis (2020)
    3. Competitive Benchmarking, By Operating Parameters
12. Impact of COVID-19 on Global Anticancer Drugs Market
13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
    1. Johnson & Johnson
    2. F. Hoffmann-La Roche Ltd.
    3. Pfizer Inc.
    4. Novartis AG
    5. Merck & Co. Inc.
    6. Bristol-Myers Squibb Company
    7. AstraZeneca PLC
    8. Astellas Pharma Inc.
    9. AbbVie Inc.
    10. Amgen
    11. Takeda Oncology Drugs Ltd.
    12. GlaxoSmithKline
    13. Sanofi
    14. Celgene Corporation
    15. Boehringer Ingelheim GmbH
    16. Teva Pharmaceuticals
    17. Eli Lilly and Company
    18. Millennium Pharmaceuticals
    19. Kolaz Biotech
    20. Other Prominent Players
14. Key Strategic Recommendations

 

 

List of Figures

 

Figure 1: Global Anticancer Drugs Devices Segmentation

 

Figure 2: Global Anticancer Drugs Devices Market Value Chain Analysis,

 

Figure 3: Company Market Share Analysis, 2020

 

Figure 4: Global Anticancer Drugs Devices Market Size, By Value (USD Million), 2017-2027

 

Figure 5: Global Anticancer Drugs Devices Market Share (%), By Drug Class, By Value, 2017-2027

 

Figure 6: Global Anticancer Drugs Devices Market Share (%), By Therapy, By Value, 2017-2027

 

Figure 7: Global Anticancer Drugs Devices Market Share (%), By Indication, By Value, 2017-2027

 

Figure 8: Global Anticancer Drugs Devices Market Share (%), By Dosage Form, By Value, 2017-2027

 

Figure 9: Global Anticancer Drugs Devices Market Share (%), By Distribution Channel, By Value, 2017-2027

 

Figure 10: Global Anticancer Drugs Devices Market Share (%), By Region, By Value, 2017-2027

 

Figure 11: North America Anticancer Drugs Devices Market Size, By Value (USD Million), 2017-2027

 

Figure 12: North America Anticancer Drugs Devices Market Share (%), By Drug Class, By Value, 2017-2027

 

Figure 13: North America Anticancer Drugs Devices Market Share (%), By Therapy, By Value, 2017-2027

 

Figure 14: North America Anticancer Drugs Devices Market Share (%), By Indication, By Value, 2017-2027

 

Figure 15: North America Anticancer Drugs Devices Market Share (%), By Dosage Form, By Value, 2017-2027

 

Figure 16: North America Anticancer Drugs Devices Market Share (%), By Distribution Channel, By Value, 2017-2027

 

Figure 17: North America Anticancer Drugs Devices Market Share (%), By Country, By Value, 2017-2027

 

Figure 18: Europe Anticancer Drugs Devices Market Size, By Value (USD Million), 2017-2027

 

Figure 19: Europe Anticancer Drugs Devices Market Share (%), By Drug Class, By Value, 2017-2027

 

Figure 20: Europe Anticancer Drugs Devices Market Share (%), By Therapy, By Value, 2017-2027

 

Figure 21: Europe Anticancer Drugs Devices Market Share (%), By Indication, By Value, 2017-2027

 

Figure 22: Europe Anticancer Drugs Devices Market Share (%), By Dosage Form, By Value, 2017-2027

 

Figure 23: Europe Anticancer Drugs Devices Market Share (%), by Distribution Channel, By Value, 2017-2027

 

Figure 24: Europe Anticancer Drugs Devices Market Share (%), By Country, By Value, 2017-2027

 

Figure 25: Asia-Pacific Anticancer Drugs Devices Market Size, By Value (USD Million), 2017-2027

 

Figure 26: Asia-Pacific Anticancer Drugs Devices Market Share (%), By Drug Class, By Value, 2017-2027

 

Figure 27: Asia-Pacific Anticancer Drugs Devices Market Share (%), By Therapy, By Value, 2017-2027

 

Figure 28: Asia-Pacific Anticancer Drugs Devices Market Share (%), By Indication, By Value, 2017-2027

 

Figure 29: Asia-Pacific Anticancer Drugs Devices Market Share (%), By Dosage Form, By Value, 2017-2027

 

Figure 30: Asia-Pacific Anticancer Drugs Devices Market Share (%), By Distribution Channel, By Value, 2017-2027

 

Figure 31: Asia-Pacific Anticancer Drugs Devices Market Share (%), By Country, By Value, 2017-2027

 

Figure 32: Latin America Anticancer Drugs Devices Market Size, By Value (USD Million), 2017-2027

 

Figure 33: Latin America Anticancer Drugs Devices Market Share (%), By Drug Class, By Value, 2017-2027

 

Figure 34: Latin America Anticancer Drugs Devices Market Share (%), By Therapy, By Value, 2017-2027

 

Figure 35: Latin America Anticancer Drugs Devices Market Share (%), By Indication, By Value, 2017-2027

 

Figure 36: Latin America Anticancer Drugs Devices Market Share (%), By Dosage Form, By Value, 2017-2027

 

Figure 37: Latin America Anticancer Drugs Devices Market Share (%), By Distribution Channel, By Value, 2017-2027

 

Figure 38: Latin America Anticancer Drugs Devices Market Share (%), By Country, By Value, 2017-2027

 

Figure 39: Middle East & Africa Anticancer Drugs Devices Market Size, By Value (USD Million), 2017-2027

 

Figure 40: Middle East & Africa Anticancer Drugs Devices Market Share (%), By Drug Class, By Value, 2017-2027

 

Figure 41: Middle East & Africa Anticancer Drugs Devices Market Share (%), By Therapy, By Value, 2017-2027

 

Figure 42: Middle East & Africa Anticancer Drugs Devices Market Share (%), By Indication, By Value, 2017-2027

 

Figure 43: Middle East & Africa Anticancer Drugs Devices Market Share (%), By Dosage Form, By Value, 2017-2027

 

Figure 44: Middle East & Africa Anticancer Drugs Devices Market Share (%), By Distribution Channel, By Value, 2017-2027

 

Figure 45: Middle East & Africa Anticancer Drugs Devices Market Share (%), By Region, By Value, 2017-2027

 

 

 

List of Tables

 

Table 1: Global Anticancer Drugs Devices Design Size, By Drug Class, By Value, 2017-2027

 

Table 2: Global Anticancer Drugs Devices Design Size, By Therapy, By Value (USD Million), 2017-2027

 

Table 3: Global Anticancer Drugs Devices Design Size, By Indication, By Value (USD Million), 2017-2027

 

Table 4: Global Anticancer Drugs Devices Design Size, By Dosage Form, By Value (USD Million), 2017-2027

 

Table 5: Global Anticancer Drugs Devices Design Size, By Distribution Channel, By Value (USD Million), 2017-2027

 

Table 6: Global Anticancer Drugs Devices Design Size, By Region, By Value (USD Million), 2017-2027

 

Table 7: North America Anticancer Drugs Devices Market Size, By Drug Class, By Value (USD Million), 2017-2027

 

Table 8: North America Anticancer Drugs Devices Market Size, By Therapy, By Value (USD Million), 2017-2027

 

Table 9: North America Anticancer Drugs Devices Market Size, By Indication, By Value (USD Million), 2017-2027

 

Table 10: North America Anticancer Drugs Devices Market Size, By Dosage Form, By Value (USD Million), 2017-2027

 

Table 11: North America Anticancer Drugs Devices Market Size, By Distribution Channel, By Value (USD Million), 2017-2027,

 

Table 12: Europe Anticancer Drugs Devices Market Size, By Drug Class, By Value (USD Million), 2017-2027

 

Table 13: Europe Anticancer Drugs Devices Market Size, By Therapy, By Value (USD Million), 2017-2027

 

Table 14: Europe Anticancer Drugs Devices Market Size, By Indication, By Value (USD Million), 2017-2027

 

Table 15: Europe Anticancer Drugs Devices Market Size, By Dosage Form, By Value (USD Million), 2017-2027

 

Table 16: Europe Anticancer Drugs Devices Market Size, By Distribution Channel, By Value (USD Million), 2017-2027

 

Table 17: the Asia-Pacific Anticancer Drugs Devices Market Size, By Drug Class, By Value (USD Million), 2017-2027

 

Table 18: the Asia-Pacific Anticancer Drugs Devices Market Size, By Therapy, By Value (USD Million), 2017-2027

 

Table 19: the Asia-Pacific Anticancer Drugs Devices Market Size, By Indication, By Value (USD Million), 2017-2027

 

Table 20: the Asia-Pacific Anticancer Drugs Devices Market Size, By Dosage Form, By Value (USD Million), 2017-2027

 

Table 21: the Asia-Pacific Anticancer Drugs Devices Market Size, By Distribution Channel, By Value (USD Million), 2017-2027

 

Table 22: Latin America Anticancer Drugs Devices Market Size, By Drug Class, By Value (USD Million), 2017-2027

 

Table 23: Latin America Anticancer Drugs Devices Market Size, By Therapy, By Value (USD Million), 2017-2027

 

Table 24: Latin America Anticancer Drugs Devices Market Size, By Indication, By Value (USD Million), 2017-2027

 

Table 25: Latin America Anticancer Drugs Devices Market Size, By Dosage Form, By Value (USD Million), 2017-2027

 

Table 26: Latin America Anticancer Drugs Devices Market Size, By Distribution Channel, By Value (USD Million), 2017-2027

 

Table 27: The Middle-East & Africa Anticancer Drugs Devices Market Size, By Drug Class, By Value (USD Million), 2017-2027

 

Table 28: The Middle-East & Africa Anticancer Drugs Devices Market Size, By Therapy, By Value (USD Million), 2017-2027

 

Table 29: The Middle-East & Africa Anticancer Drugs Devices Market Size, By Indication, By Value (USD Million), 2017-2027

 

Table 30: The Middle-East & Africa Anticancer Drugs Devices Market Size, By Dosage Form, By Value (USD Million), 2017-2027

 

Table 31: The Middle-East & Africa Anticancer Drugs Devices Market Size, By Distribution Channel, By Value (USD Million), 2017-2027

 

Table 32: Johnson & Johnson Financial Analysis

Table 33: Johnson & Johnson Business Overview

Table 34: F. Hoffmann-La Roche Ltd.Financial Analysis

Table 35: F. Hoffmann-La Roche Ltd.Business Overview

Table 36: Pfizer Inc.Financial Analysis

Table 37: Pfizer Inc. Business Overview

Table 38: Novartis AGFinancial Analysis

Table 39: Novartis AG Business Overview

Table 40: Merck & Co. Inc. Financial Analysis

Table 41: Merck & Co. Inc.Business Overview

Table 42: Bristol-Myers Squibb Company Financial Analysis

Table 43: Bristol-Myers Squibb Company Business Overview

Table 44: AstraZeneca PLC Financial Analysis

Table 45: AstraZeneca PLC Business Overview

Table 46: Astellas Pharma Inc. Financial Analysis

Table 47: Astellas Pharma Inc. Business Overview

Table 48: AbbVie Inc.Financial Analysis

Table 49: AbbVie Inc.Business Overview

Table 50: Amgen Financial Analysis

Table 51: Amgen Business Overview

Table 52: Takeda Oncology Drugs Ltd. Financial Analysis

Table 53: Takeda Oncology Drugs Ltd.Financial Analysis

Table 52: GlaxoSmithKline Financial Analysis

Table 53: GlaxoSmithKline Business Overview

Table 54: Sanofi Financial Analysis

Table 55: Sanofi Business Overview

Table 56: Celgene Corporation Financial Analysis

Table 57: Celgene Corporation Business Overview

Table 58: Boehringer Ingelheim GmbH Financial Analysis

Table 59: Boehringer Ingelheim GmbH Business Overview

Table 60: Teva Pharmaceuticals Financial Analysis

Table 61: Teva Pharmaceuticals Business Overview

Table 62: Eli Lilly and Company Financial Analysis

Table 63: Eli Lilly and Company Business Overview

Table 64: Millennium PharmaceuticalsFinancial Analysis

Table 65: Millennium Pharmaceuticals Business Overview

Table 66: Kolaz Biotech Financial Analysis

Table 67: Kolaz Biotech Business Overview